Skip to main content
. 2019 Mar 19;42(6):760–767. doi: 10.1080/10790268.2019.1584259

Table 2. Predictors of use of pharmacological treatment for osteoporosis (comparator is all others who are not given any pharmacological therapy for osteoporosis, i.e. entire cohort from FY2005 – FY2015).

Predictors Univariate Multivariate
OR 95% CI OR 95% CI
Demographics
 Age (> 50 vs. ≤ 50) 1.25 1.10−1.43 1.6 1.31−1.94
 Race        
  (Black vs. White) 0.47 0.39−0.58 0.43 0.33−0.57
  (Asian vs. White) 0.76 0.33−1.76 0.85 0.28−2.57
  (American Indian/Alaskan vs. White) 0.78 0.40−1.49 0.64 0.24−1.69
 (Hawaiian/Pacific Islander vs. White) 1.27 0.74−2.15 1.14 0.52−2.51
 Ethnicity (Hispanic vs. Non-Hispanic) 0.89 0.66−1.21 0.75 0.49−1.15
 Sex (Female vs. Male) 3.39 2.59−4.44 4.09 2.74−6.09
Clinical Factors
 BMI (Underweight vs Normal) 1.04 0.79−1.36 1.14 0.78−1.66
 BMI (Overweight vs Normal) 0.87 0.75−1.00 0.84 0.67−1.04
 BMI (Obese vs Normal) 0.59 0.49−0.71 0.59 0.45−0.76
 Opioid 1 Year Prior to Index* Date (Yes vs. No) 1.93 1.69−2.19 1.24 1.01−1.51
 Corticosteroids 1 Year Prior to Index* Date (Yes vs. No) 3.54 2.80−4.48 1.92 1.27−2.92
 Anticonvulsants 1 Year Prior to Index* Date (Yes vs. No) 1.56 1.36−1.79 1.14 0.92−1.41
SCI-Related Factors
 SCI Level (Paraplegia vs. Tetraplegia) 1.27 1.10−1.45 1.1 0.91−1.34
 SCI Extent (Complete vs. Incomplete) 1.43 1.24−1.66 1.26 1.04−1.53
DXA 1 Year Prior to Index Date* (Yes vs. No) 87.62 66.09−116.17 84.03 59.80−118.07
Lower Extremity or Pathological Fracture 1 Year Prior to Index Date* (Yes vs. No) 7.02 5.82−8.46 5.43 4.13−7.15

CI, confidence interval; OR, odds ratio.

*Index date for those with a filled prescription was the date of their first filled prescription.

Index date for those without a filled script was the date of their first utilization plus 905 days.